Docetaxel | C43H53NO14 - PubChem
Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial - The Lancet Oncology
RCSB PDB - TXL Ligand Summary Page
Docetaxel | Marketing Authorisations | MA | Europe | PharmaCompass.com
Docetaxel Teva Liquid 140mg/7ml Durchstechflasche in der Adler Apotheke
Docetaxel Teva Pharma, INN-docetaxel
RCSB PDB - TXL Ligand Summary Page
New Anti-Cancer Drug | Financial Tribune
ДОЦЕТАКСЕЛ-ТЕВА (DOCETAXEL-TEVA) - поиск и резервирование лекарств в России
Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial - The Lancet Oncology
Docetaxel (RP-56976) | Microtubule Depolymerization Inhibitor | MedChemExpress
DOCETAXEL ANHYDROUS
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial - European Journal of Cancer
Enzalutamide Antitumour Activity Against Metastatic Castration-resistant Prostate Cancer Previously Treated with Docetaxel and Abiraterone: A Multicentre Analysis - European Urology
Rx Item-Docetaxel Injection 20MG 2 ML Multi Dose Vial by Sa
Docetaxel Teva, INN-docetaxel
Docetaxel Teva Liquid 140mg/7ml Durchstechflasche in der Adler Apotheke
Docetaxel 20 mg / 1 mL | Laboratorio Chile | Teva
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design -
Rx Item-Docetaxel 20Mg/Ml(1) Vial 1Ml By Actavis Pharma
Physical and chemical stability of docetaxel infusions in polyolef in bags containing 0.9% sodium chloride or 5% glucose at 5°C and 25°C | Semantic Scholar
TAXOTERE
Teva's generic of : Docetaxel Injection Concentrate
